Abstract
The increasing prevalence of obesity and diabetes is an urgent worldwide health challenge. Now in Cell Stem Cell, Yue et al. (2017) report a proof-of-concept study using genetically engineered skin transplants that produce the incretin GLP-1 to prevent diet-induced obesity, suggesting a powerful approach for treating metabolic disorders.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 153-155 |
Seitenumfang | 3 |
Fachzeitschrift | Cell Stem Cell |
Jahrgang | 21 |
Ausgabenummer | 2 |
DOIs | |
Publikationsstatus | Veröffentlicht - 3 Aug. 2017 |